Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in the Nordic Countries, Denmark, Finland, Iceland, Norway and Sweden, or involving organisations from these countries.

Total search results: 908 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Novo Group–Bluebird Bio: gene therapy, 201910–202209 collab r+d 3y utilising megaTAL technology to develop hemophilia A gene therapies 2019-10-09
Vivoryon–SEVERAL: investment, 201910– public rights offering €30m–€70m incl Claus Chrisitansen + Den Danske Forskningsfond + T&W Holding + MorphoSys 2019-10-08
STipe Therapeutics–SEVERAL: investment, 201909 financing round Series A €20m co-led by Arix Bioscience + Novo Holdings 2019-09-30
Themis Bioscience–Hadean Ventures: investment, 201909 financing round Series D totalling €40m incl new + co-lead investor Hadean Ventures 2019-09-18
Themis Bioscience–SEVERAL: investment, 201909 financing round Series D €40m co-led by Farallon Capital + Hadean Ventures 2019-09-18
Alder Biopharmaceuticals–Lundbeck: investment, 201909 acquisition tender offer in cash + CVRs up to $1.95b net of cash ANNOUNCED 2019-09-16
Orion Corp–Genedata: bioinformatics, 201909– supply license to Genedata Biologics as SaaS for large-molecule r+d to Orion Pharma 2019-09-11
Genmab–Tempus: AI-based drug discovery, 201909– strateg collab multi-year r+d targets + biomarker for personalised cancer drugs 2019-09-09
Sigrid Therapeutics–Axilium Capital: investment, 201909 financing round totalling $1.6m incl co-investor Axilium Capital 2019-09-05
Sigrid Therapeutics–Joyance Partners: investment, 201909 financing round totalling $1.6m incl co-lead investor Joyance Partners 2019-09-05
Sigrid Therapeutics–PERSON: investment, 201909 financing round totalling $1.6m incl co-investor Karsten Inde 2019-09-05
Sigrid Therapeutics–PERSON: investment, 201909 financing round totalling $1.6m incl co-lead investor Pär Gellerfors 2019-09-05
Sigrid Therapeutics–SEVERAL: investment, 201909 financing round $1.6m led by Joyance Partners + Pär Gellerfors 2019-09-05
Curetis–OpGen: investment, 201909– reverse merger with Curetis shareholders holding 72.5% of combined entity 2019-09-04
Protelux (RU)–Unibio: protein production from methane, 201908 collab existing buidling + operating plant for Uniprotein production in Russia 2019-08-28
Unibio–SEVERAL: investment, 201908 financing round $15m (£12.4m) from existing + new shareholders led by West Hill Capital 2019-08-28
Unibio–West Hill Capital: investment, 201908 financing round totalling $15m (£12.4m) incl lead investor West Hill Capital 2019-08-28
Nanovi–SEVERAL: investment, 201908 financing round DKK19m from existing investors 2019-08-27
Biotheus–Alligator Bioscience: therapeutic antibodies, 201908– license to Ab from Alligator-Gold library for bispecific molecules for Greater China 2019-08-20
Cytena–Cellink: investment, 201908 acquisition €30.25m of Cytena GmbH by Cellink AB 2019-08-05
Alizé Pharma–SEVERAL: investment, 201907 financing round Series A €67m of Alizé Pharma 3 led by LSP 2019-07-31
Genmab–SEVERAL: investment, 201907 US IPO $581.6m with 28.5m+4.275m ADSs at $17.75/ADS with 10 ADSs/share at Nasdaq Global Select Market 2019-07-22
Medicxi Ventures–JnJ: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–Novartis: investment, 201907 closing totalling €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Medicxi Ventures–SEVERAL: investment, 201907 closing €400m of Medicxi III fund incl cornerstone investors + Novartis + JJDC 2019-07-19
Genmab–Blink Biomedical: therapeutic antibodies, 201907– license to use CD47 Abs in DuoBodies $2.25m upfront + up to $200m per product plus royalties 2019-07-12
Nanoform–Notch Communications: public relations, 201907 service existent by Notch 2019-07-10
IGM Biosciences–Haldor Topsøe: investment, 201907 financing round Series C totalling $102m incl existing + founding investor Haldor Topsøe Holding A/S 2019-07-08
IGM Biosciences–SEVERAL: investment, 201907 financing round Series C $102m incl Redmile Group + Janus Henderson + Vivo Capital et al 2019-07-08
Danaher–Cobo Technologies: protein expression analysis, 201907– collab co-marketing PIPPR platform with SWATH Acquisition + Sciex TripleTOF 6600 2019-07-05
Nanoform–SEVERAL: investment, 201907 private placement €10m incl Ilmarinen Mutual Pension Insurance + Mandatum Life Insurance 2019-07-03
ExpreS2ion Biotech–ERS Genomics: CRISPR technology, 201907– license non-excl €na for use + commercialisation of products from ERS Genomics 2019-07-01
Yahong Meditech–Photocure: Cevira®, 201907– license ww developm + commercialisation to Asieris up to $250m milestones + royalties 2019-07-01
Sanifit–Lundbeck: investment, 201906 financing round Series D totalling €55.2m incl existing + co-investor Lundbeckfonden Ventures 2019-06-26
UmanDiagnostics–Quanterix: investment, 201906–201907 acquisition $16m in cash + $6.5m in common stock 2019-06-26
Forendo Pharma–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Sword Health–Vesalius Biocapital: investment, 201906 existent investment of Vesalius Biocapital III fund 2019-06-25
Karolinska Institutet–BGI: DNA sequencing, 201906– collab using DNBSEQ techn for shotgun metagenomics data from microbiome biobank MGI Tech 2019-06-20
Spero Therapeutics–Novo Group: investment, 201906– direct offering common stock up to $10m in two tranches of $5m to Novo REPAIR Fund 2019-06-13
JnJ–Genmab: antibody cancer drug, 201906– collab + excl ww license + option agreem for HexaBody-CD38 monoclonal antibody 2019-06-11
Merck (US)–Agilent: molecular companion diagnostics, 201906 collab existent developm of PD-L1 IHC 22CR pharmDx for use with Keytruda 2019-06-11
Saga Diagnostics–Fårö Capital: investment, financing round totalling SEK40m (€3.7m) incl existing + co-investor Fårö Capital 2019-06-11
Saga Diagnostics–Gunnar Nilsson Cancer Foundation: investment, financing round totalling SEK40m (€3.7m) incl existing + co-investor GNCF 2019-06-11
Saga Diagnostics–Hadean Ventures: investment, financing round totalling SEK40m (€3.7m) incl new + lead investor Hadean Ventures 2019-06-11
Saga Diagnostics–SEVERAL: investment, financing round SEK40m (€3.7m) led by new investor Hadean Ventures 2019-06-11
Yingsheng Biotechnology–Biotage: clinical mass spectrometry, 201906– collab strategic + OEM sale in China by Shandong Yingsheng Biotechnology 2019-06-04
Oxford BioMedica–Novo Group: investment, 201905–201906 investment £45.3m + optional £8.2m with 6.6m+1.2m new shares at £6.9/share 2019-05-28
Fujifilm–Genovis: enzymes, 201905– collab distribution of SmartEnzymes in Japan + Taiwan + Singapore by Fujifilm Wako Pure Chemical 2019-05-16
Symphogen–SEVERAL: investment, 201905– capital increase up to DKK572m incl DKK182m debt conversion from existing shareholders 2019-05-15
Therachon–Novo Group: investment, 201905 existing investor Novo Holdings 2019-05-08
Abide Therapeutics–Lundbeck: investment, 201905 acquisition $250m upfront + $150m milestones of Abide by Lundbeck 2019-05-06
United States (govt)–Cobo Technologies: genome editing, 201904– collab Cobo beomes member of NIST Genome Editing Consortium 2019-04-15
Gilead–Novo Group: drug development, 201904– collab clinical research for NASH combining semaglutide + cilofexor + firsocostat Novo Nordisk 2019-04-12
Probiodrug–SEVERAL: investment, 201904 private placement €8.2m net €7.65m with 4.1m new shares at €2m led by Claus Christiansen et al. 2019-04-09
Gesynta Pharma–SEVERAL: investment, 201904 financing round €6m led by Industrifonden + incl group of private life science investors 2019-04-04
Gesynta Pharma–Sweden (govt): investment, 201904 financing round totalling €6m incl lead investor Industrifonden 2019-04-04
Chr Hansen–Lonza: live biotherapeutics, 201904– collab establishment 50/50 joint venture for developing + manufacturing microbiome treatments 2019-04-02
Cytena–High-Tech Gründerfonds: investment, 201903 financing round Series A totalling €3.m incl HTGF + two private investors 2019-03-26
Cytena–SEVERAL: investment, 201903 financing round Series A €3.m from HTGF + two private investors 2019-03-26
Lundbeck–Enamine: chemical compound libraries, 201903– supply expansion discovery chemistry services by Enamine 2019-03-26
Verona Pharma–Novo Group: investment, 201903 existent investment Novo Holdings owns 11.76% shareholding in Verona Pharma plc 2019-03-21
Biogen–Fujifilm: biologics contract manfuacturing, 201903– supply manufacturing of biologicals for Biogen incl Tysabri 2019-03-12
Biogen–Fujifilm: investment, 201903– acquisition up to $890m in cash of Biogen’s Biologics Manufacturing Site in Hillerød Denmark 2019-03-12
Snipr Biome–Life Sciences Partners: investment, 201903 financing round Series A totalling $50m incl co-lead investor LSP 2019-03-11
Snipr Biome–Lundbeck: investment, 201903 financing round Series A totalling $50m incl existing + co-lead investor Lundbeckfonden Emerge 2019-03-11
Snipr Biome–North-East Family Office: investment, 201903 financing round Series A totalling $50m incl co-investor North-East Family Office 2019-03-11
Snipr Biome–SEVERAL: investment, 201903 financing round Series A $50m co-led by Lundbeckfonden Emerge + Life Sciences Partners 2019-03-11
Snipr Biome–Wellington Partners: investment, 201903 financing round Series A totalling $50m incl co-investor Wellington Partners 2019-03-11
Ascendis Pharma–SEVERAL: investment, 201903– public offering $400m+$60m ADSs 2019-03-04
CEPI–CureVac: mRNA vaccine production technology, 201903–202202 collab up to $34m developm of mobile mRNA printing facility 2019-03-01
Mobidiag–Consilium: public relations, 201902 service existent by CSC 2019-02-25
Wren Therapeutics–Baupost Group: investment, 201901 financing round Series A totalling £18m including lead investor The Baupost Group 2019-01-22
Wren Therapeutics–LifeForce Capital: investment, 201901 financing round Series A totalling £18m including co-investor LifeForce Capital 2019-01-22
Wren Therapeutics–SEVERAL: investment, 201901 financing round Series A £18m from Baupost Group + LifeForce Capital + high net worth individuals 2019-01-22
Samplix–EU (govt): grant, 201901– Horizon 2020 SME Instrument Program Grant €1.9m 2019-01-10
BC Platforms–MedEngine (FI): medical data science services, 201901– collab strategic partnership to provide solutions for pharma + health sectors 2019-01-09
10x Genomics–Fidelity: investment, 201901 financing round Series D extension totalling $35m incl existing + co-investor Fidelity 2019-01-07
10x Genomics–Meritech Capital: investment, 201901 financing round Series D extension totalling $35m incl existing + lead investor Meritech Capital 2019-01-07
10x Genomics–SEVERAL: investment, 201901 financing round Series D extension $35m led by Meritech Capital + incl Fidelity + Wells Fargo 2019-01-07
Minervax–Novo Group: investment, 2018 investment €3.6m by Novo REPAIR Impact Fund 2018-12-31
Procarta Biosystems–Novo Group: investment, 2018 investment €1.5m by Novo REPAIR Impact Fund 2018-12-31
Spatial Transcriptomics–10x Genomics: investment, 201812 acquisition of Spatial by 10x Genomics 2018-12-10
Hookipa–Valneva: drug development services, 201812–202111 collab + manufacturing agreem for developm of immunotherapies with Valneva Sweden AB 2018-12-06
Leo Pharma–Evotec: drug discovery services, 201812– collab €na integrated drug discovery to generate leads against innovative dermatic targets 2018-12-04
Aprea–SEVERAL: investment, 201812 financing round Series C €50m led by new investor Redmile Group 2018-12-02
Dispendix–Cellink: investment, 201811 acquisition €5m of Dispendix GmbH by Cellink AB 2018-11-30
BridgeBio–Leo Pharma: investment, 201811 acquisition minority stake in PellePharm Inc plus r+d funding + plus option to aquire PellePharm 2018-11-20
Symphogen–Thermo Fisher: mass spectrometer, 201810 supply Q Exactive Plus Orbitrap LC-MS/MS with BioPharma Option for biopharma QC 2018-10-29
Thermo Fisher–Symphogen: mass spectrometry, 201810– collab developm biopharma QC workflows using Q Exactive Plus Orbitrap LC-MS/MS system 2018-10-29
Galecto Biotech–BPCE: investment, 201810 financing round Series C totalling €79m incl new + co-investor Seventure Partners 2018-10-26
Galecto Biotech–OrbiMed: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor OrbiMed 2018-10-26
Galecto Biotech–SEVERAL: investment, 201810 financing round Series C €79m co-led by Ysios Capital + OrbiMed 2018-10-26
Galecto Biotech–Ysios Capital: investment, 201810 financing round Series C totalling $79m incl new + co-lead investor Ysios Capital 2018-10-26
Euformatics–EU (govt): grant, 201810– H2020 grant €700k for participation in GEMMA project 2018-10-25
Milestone Pharmaceuticals–Forbion: investment, 201810 financing round private totalling $80m incl existing + co-investor Forbion 2018-10-25
Milestone Pharmaceuticals–Novo Group: investment, 201810 financing round private totalling $80m incl existing + co-investor Novo Holdings A/S 2018-10-25
Milestone Pharmaceuticals–SEVERAL: investment, 201810 financing round private $80m led by RTW Investments 2018-10-25
Zelluna–Image Box: public relations, 201810 supply service existent by Image Box PR 2018-10-24
Immunicum–SEVERAL: investment, 201810– capital increase SEK351m with 40.3m new shares at SEK8.5/share 2018-10-16
Rgenix–Novo Group: investment, 201810 financing round Series C totalling $40m incl existing + co-investor Novo Holdings AS 2018-10-09
1 2 3 4 5 6 7 8 9 10  next pagenext page



Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group BIO-Europe 2019 Partnering Report BEU2019 650x80px

» top